These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25196979)

  • 1. Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Hultcrantz M; Pfeiffer RM; Björkholm M; Goldin LR; Turesson I; Schulman S; Landgren O; Kristinsson SY
    J Thromb Haemost; 2014 Nov; 12(11):1816-21. PubMed ID: 25196979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.
    Kristinsson SY; Koshiol J; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
    J Natl Cancer Inst; 2010 Apr; 102(8):557-67. PubMed ID: 20181958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
    Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
    Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005.
    Kristinsson SY; Eloranta S; Dickman PW; Andersson TM; Turesson I; Landgren O; Björkholm M
    Am J Hematol; 2013 Jan; 88(1):60-5. PubMed ID: 23165980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.
    Kristinsson SY; Pfeiffer RM; Björkholm M; Goldin LR; Schulman S; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
    Blood; 2010 Jun; 115(24):4991-8. PubMed ID: 20299513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study.
    Brandefors L; Sander B; Lundqvist K; Kimby E
    Br J Haematol; 2022 Mar; 196(6):1362-1368. PubMed ID: 34959252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016.
    Dalal NH; Dores GM; Curtis RE; Linet MS; Morton LM
    Br J Haematol; 2020 Jun; 189(6):1107-1118. PubMed ID: 32090327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
    Vajdic CM; Landgren O; McMaster ML; Slager SL; Brooks-Wilson A; Smith A; Staines A; Dogan A; Ansell SM; Sampson JN; Morton LM; Linet MS
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):87-97. PubMed ID: 25174029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.
    Naderi N; Yang DT
    Arch Pathol Lab Med; 2013 Apr; 137(4):580-5. PubMed ID: 23544948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-acquired infections associated with increased risk of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia.
    McShane CM; Murray LJ; Engels EA; Anderson LA
    Br J Haematol; 2014 Mar; 164(5):653-8. PubMed ID: 24528127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies--A population-based study from northern Sweden.
    Brandefors L; Kimby E; Lundqvist K; Melin B; Lindh J
    Acta Oncol; 2016; 55(1):91-8. PubMed ID: 26559865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases.
    Lin P; Mansoor A; Bueso-Ramos C; Hao S; Lai R; Medeiros LJ
    Am J Clin Pathol; 2003 Aug; 120(2):246-53. PubMed ID: 12931555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden unexpected death after initial infusion of rituximab for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma: an autopsy case.
    Ichimata S; Hata Y; Nomoto K; Sato T; Nishida N
    Diagn Pathol; 2024 Jun; 19(1):89. PubMed ID: 38943126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: an evolving concept.
    Lin P; Medeiros LJ
    Adv Anat Pathol; 2005 Sep; 12(5):246-55. PubMed ID: 16210920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.
    Kristinsson SY; Goldin LR; Turesson I; Björkholm M; Landgren O
    Acta Haematol; 2012; 127(3):173-7. PubMed ID: 22310551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Laboratory, and Bone Marrow Findings of 31 Patients With Waldenström Macroglobulinemia.
    Ahn A; Park CJ; Cho YU; Jang S; Seo EJ; Lee JH; Yoon DH; Suh C
    Ann Lab Med; 2020 May; 40(3):193-200. PubMed ID: 31858758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features of 16 cases of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia].
    Wang JJ; Jing HM; Shen HW; Xu JS; Li M; Gao ZF; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1494-8. PubMed ID: 21176358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network.
    Varettoni M; Boveri E; Zibellini S; Tedeschi A; Candido C; Ferretti VV; Rizzo E; Doni E; Merli M; Farina L; Goldaniga M; Gallì A; Rattotti S; Frustaci AM; Deodato M; Bandiera L; Isimbaldi G; Uccella S; Cabras AD; Gianelli U; Baldini L; Paulli M; Arcaini L
    Am J Hematol; 2019 Nov; 94(11):1193-1199. PubMed ID: 31378966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.
    Roberts MJ; Chadburn A; Ma S; Hyjek E; Peterson LC
    Am J Clin Pathol; 2013 Feb; 139(2):210-9. PubMed ID: 23355206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemia.
    Olszewski AJ; Chen C; Gutman R; Treon SP; Castillo JJ
    Br J Haematol; 2017 Oct; 179(1):106-115. PubMed ID: 28677830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.